CLOFARABINE is a Intravenous Injection in the Human Prescription Drug category. It is labeled and distributed by Fosun Pharma Usa Inc.. The primary component is Clofarabine.
| Product ID | 72266-108_8c67d5f8-f1c5-8045-e053-2995a90af8b4 |
| NDC | 72266-108 |
| Product Type | Human Prescription Drug |
| Proprietary Name | CLOFARABINE |
| Generic Name | Clofarabine |
| Dosage Form | Injection |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2019-08-19 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA207831 |
| Labeler Name | Fosun Pharma USA Inc. |
| Substance Name | CLOFARABINE |
| Active Ingredient Strength | 1 mg/mL |
| Pharm Classes | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2019-08-19 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA207831 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | ML |
| Marketing Start Date | 2019-08-19 |
| Ingredient | Strength |
|---|---|
| CLOFARABINE | 1 mg/mL |
| SPL SET ID: | e956b1e0-2829-4872-8c09-99462d60e922 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0955-1746 | clofarabine | clofarabine |
| 43598-309 | Clofarabine | Clofarabine |
| 49315-003 | CLOFARABINE | clofarabine |
| 50742-512 | CLOFARABINE | clofarabine |
| 55150-326 | CLOFARABINE | CLOFARABINE |
| 60505-6166 | Clofarabine | clofarabine |
| 63323-572 | CLOFARABINE | clofarabine |
| 67457-546 | clofarabine | clofarabine |
| 68083-386 | Clofarabine | Clofarabine |
| 70121-1236 | Clofarabine | Clofarabine |
| 71288-128 | Clofarabine | Clofarabine |
| 72266-108 | CLOFARABINE | CLOFARABINE |
| 0024-5860 | Clolar | clofarabine |
| 0024-5917 | Clolar | clofarabine |